Last reviewed: May 30, 2026
Last updated: May 30, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
NAD+ (nicotinamide adenine dinucleotide) is available through licensed compounding pharmacies, specialized anti-aging clinics, telemedicine providers, and research institutions, though access varies by state and regulatory environment. NAD+ levels naturally decline with age—dropping approximately 50% between age 20 and 60—making assessment of your baseline status a reasonable first step.
If you're exploring NAD+ or other metabolic-support therapies, understanding your baseline biomarkers and genetic predispositions can help you have a more informed conversation with your provider about which options align with your health goals and individual physiology.
Understanding NAD+ and Why Access Matters
NAD+ functions as a coenzyme in cellular energy production, DNA repair, and metabolic regulation. It is found naturally in all cells and declines with age, oxidative stress, and certain metabolic conditions. Many individuals explore NAD+ supplementation to support energy, cognitive function, and cellular resilience.
Access to NAD+ has expanded in recent years due to growing research interest and consumer demand, but quality, dosing, formulation, and regulatory status vary significantly across providers and delivery methods. Provider oversight remains essential to ensure safety and appropriate use.
Where to Access NAD+: A Clinical Comparison Framework
NAD+ is available through multiple channels, each with distinct regulatory oversight, cost, and clinical support levels. The following framework outlines key differences to help guide your provider conversation and decision-making process.
| Access Channel |
Typical Cost |
Regulatory Oversight |
Provider Involvement |
| Licensed Compounding Pharmacies |
$200–$600/month (injectable/oral) |
State pharmacy board + USP <797> |
Requires valid prescription |
| Specialized Anti-Aging Clinics |
$500–$2000/infusion |
Variable; clinic-based protocols |
Direct provider assessment |
| Direct-to-Consumer Telemedicine |
$150–$400/month |
Limited oversight; state-dependent |
Telehealth consultation required |
| Research Institutions/Trials |
Often no cost |
IRB-regulated; evidence-focused |
Research protocol + informed consent |
Assessing Your Biomarker Baseline Before Starting NAD+
Before initiating NAD+ therapy, establishing baseline biomarkers—such as NAD+ blood levels, metabolic panel, mitochondrial function indicators, and inflammatory markers—can provide clinical context for your provider's decision and help track response over time.
Common baseline markers include NAD+/NADH ratio, lactate, pyruvate, and markers of oxidative stress (malondialdehyde, 8-OHdG). Some providers also assess mitochondrial ATP production and metabolic flexibility to inform whether NAD+ supplementation aligns with your specific physiology.
Safety Considerations and Who Should Seek Provider Guidance
NAD+ therapy is generally well-tolerated, but certain populations—including pregnant/nursing women, individuals with history of cancer (NAD+ may influence tumor metabolism), and those on specific medications affecting NAD+ pathways—should consult a provider before starting. Dosing, frequency, and formulation vary widely.
A qualified healthcare provider can assess your medical history, current medications, metabolic status, and health goals to determine whether NAD+ is appropriate and, if so, which delivery method and dosing regimen best fit your individual clinical picture.
How PlexusDx Supports a More Personalized Approach
PlexusDx's Precision Peptide Genetic Test may help provide context for your broader metabolic wellness profile by revealing predispositions in key peptide and metabolic pathways—including FTO (metabolic regulation), MC4R (satiety and energy balance), and mitochondrial-relevant variants. This information can support a more personalized conversation with your provider about whether metabolic-support therapies like NAD+ align with your genetic predispositions.
The genetic test reveals predispositions in peptide pathways related to energy metabolism and cellular function, not exact responses to NAD+ therapy. Interpretation of results should always be done with a qualified healthcare provider who can integrate genetic insights with your biomarkers, medical history, and health goals.
Understanding your genetic predispositions in metabolic and energy-related pathways can help you and your provider evaluate whether NAD+ support fits into a broader, personalized wellness strategy—particularly if you are also exploring peptide therapies or other precision-medicine approaches to optimize metabolic health.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $179-$229/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Do I need a prescription to buy NAD+ supplements?
It depends on the formulation and state regulations. Injectable NAD+ and prescription-grade oral formulations require a provider prescription. Over-the-counter NAD+ precursors (NR, NMN) are available without prescription but vary in purity and bioavailability.
What is the typical cost of NAD+ therapy, and does insurance cover it?
Injectable NAD+ infusions range from $500–$2000 per session; compounded forms cost $200–$600 monthly. Oral precursors (NR, NMN) range from $30–$150 monthly. Insurance rarely covers NAD+ therapy off-label, as it is not FDA-approved for longevity or age-related decline.
How do I know if NAD+ therapy is right for me?
A qualified healthcare provider can review your baseline NAD+ levels, energy and metabolic markers, medical history, and health goals to determine whether NAD+ supplementation is appropriate. Baseline biomarker assessment is recommended before starting therapy.
Are there side effects or safety concerns with NAD+ therapy?
NAD+ is generally well-tolerated. Rare side effects include nausea, flushing, and headache. Certain populations—including those with cancer history or on specific medications—should consult a provider before starting NAD+ due to potential interactions with cellular metabolism.
How does genetic testing relate to NAD+ or metabolic support therapies?
Genetic predispositions in metabolic pathways (FTO, MC4R, mitochondrial genes) may provide context for your individual metabolic efficiency and energy-regulation capacity. PlexusDx's Precision Peptide Genetic Test reveals these predispositions, which can be discussed with your provider alongside NAD+ considerations.
Related Reading
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Mic B12 Benefits: Biomarker Context and Clinical Evidence for Personalized Use
Where To Get Sermorelin: Access Routes and Clinical Considerations